Boston Scientific beefs up heart device portfolio with $14.5 billion Penumbra deal

Source: CNBC Top Stories | Published: January 15, 2026, 12:47 pm | Read Original

Neutral 0.0

Boston Scientific said on Thursday it will buy ⁠medtech firm Penumbra in a deal valued at ‍about $14.5 billion ‍to ‍expand its portfolio of cardiovascular devices.

Read Source Login to use Pulse AI

Pulse AI Analysis

Pulse analysis not available yet. Click "Get Pulse" above.

This analysis was generated using Pulse AI, Glideslope's proprietary AI engine designed to interpret market sentiment and economic signals. Results are for informational purposes only and do not constitute financial advice.

More Like This

Market & Industry Analysis Straight to Your Inbox

Glideslope AI

Boston Scientific beefs up heart device portfolio with $14.5 billion Penumbra deal

Boston Scientific said on Thursday it will buy ⁠medtech firm Penumbra in a deal valued at ‍about $14.5 billion ‍to ‍expand its portfolio of cardiovascular devices.

CNBC Top Stories • Jan 15, 2026 • Found on Glideslope.ai

Post hash: 1ej0pmi • glideslope.ai/post/1ej0pmi

Sentiment

Neutral • Score: 0.0

-100 (Bearish) +100 (Bullish)

Fraywire Market Portal, Breaking Metrics Newsletter, and Glideslope AI are designed for informational purposes only. The content provided across these platforms—including, but not limited to, stock and crypto watchlists, price tracking, trade tracking, sentiment analysis, and news articles—should not be construed as financial advice or research reports. Users are encouraged to conduct their own research and consult with qualified financial professionals before making any investment decisions. While we strive to ensure the accuracy, completeness, and reliability of the information provided, Fraywire, Breaking Metrics, and Glideslope AI make no guarantees or warranties regarding the content's validity. By using these platforms, you acknowledge and agree that you are solely responsible for your own investment decisions and actions. Fraywire, Breaking Metrics, and Glideslope AI shall not be held liable for any losses or damages resulting from the use of the information provided.

Get Connected

Fraywire & Glideslope AI are Breaking Metrics productions.
Contact the developer for advertising opportunities, questions, and more at roy@rmahd.com

○ Subscribe
○ Fraywire+
○ Glideslope AI
○ Blog
○ RMAHD
○ Merch!

Pulse AI Analysis

Related Insights

More Like This

Trump imposes 25% tariff on Nvidia AI chips and others, citing national security

Boston Scientific is buying Penumbra for $14.5 billion, gaining entry to ‘fast-growing’ vascular segments

Hundreds of Millions of Audio Devices Need a Patch to Prevent Wireless Hacking and Tracking

What to know about Havana Syndrome and a device that might be linked to it

Verizon customers nationwide left unable to text and call after massive network outage

FMCSA keeps pressure on non-compliant ELD vendors

Market & Industry Analysis Straight to Your Inbox

My Notes